Global BCG Vaccine for Tuberculosis (TB) Market Growth 2025-2031

The global BCG Vaccine for Tuberculosis (TB) market size is predicted to grow from US$ 80.8 million in 2025 to US$ 97 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031.

BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.

Key driver for the BCG vaccine market is the increasing prevalence of tuberculosis (TB) in various regions, especially in countries with lower healthcare resources. Rising TB cases have driven governments and global health organizations, like the World Health Organization (WHO), to actively promote TB vaccination programs to curb the spread of the disease. Efforts to increase BCG vaccine coverage in high-risk areas and the focus on reducing childhood TB have further propelled demand, creating a sustained need for vaccine supply and development.

A major challenge in the BCG vaccine market is the variability in its effectiveness, especially against pulmonary TB in adults. This inconsistency in protection levels has led to cautious adoption in some regions with lower TB rates. Moreover, the emergence of multi-drug-resistant TB strains complicates the market, as BCG is not effective against these resistant strains. These limitations emphasize the need for alternative vaccines or treatments, affecting the long-term outlook for BCG as a standalone solution in TB prevention.

LP Information, Inc. (LPI) ' newest research report, the “BCG Vaccine for Tuberculosis (TB) Industry Forecast” looks at past sales and reviews total world BCG Vaccine for Tuberculosis (TB) sales in 2024, providing a comprehensive analysis by region and market sector of projected BCG Vaccine for Tuberculosis (TB) sales for 2025 through 2031. With BCG Vaccine for Tuberculosis (TB) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world BCG Vaccine for Tuberculosis (TB) industry.

This Insight Report provides a comprehensive analysis of the global BCG Vaccine for Tuberculosis (TB) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on BCG Vaccine for Tuberculosis (TB) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global BCG Vaccine for Tuberculosis (TB) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BCG Vaccine for Tuberculosis (TB) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BCG Vaccine for Tuberculosis (TB).

This report presents a comprehensive overview, market shares, and growth opportunities of BCG Vaccine for Tuberculosis (TB) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Immune Type
Therapy Type

Segmentation by Application:
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
BioFarma
GSBPL
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Torlakinstitut
IVAC – Institute of Vaccines and Medical Biologicals
Institut Pasteur de Tunis

Key Questions Addressed in this Report

What is the 10-year outlook for the global BCG Vaccine for Tuberculosis (TB) market?

What factors are driving BCG Vaccine for Tuberculosis (TB) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do BCG Vaccine for Tuberculosis (TB) market opportunities vary by end market size?

How does BCG Vaccine for Tuberculosis (TB) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.